Relationship between Helicobacter pylori virulence factors and regulatory cytokines as predictors of clinical outcome

Microbes and Infection

Volumn 9, Issue 4, 2007, Pages 428-434

  Serrano, Carolina ^a   Diaz, Maria Ines ^a   Valdivia, Alejandra ^a   Godoy, Alex ^a   Peña, Alfredo ^a   Rollan, Antonio ^a   Kirberg, Arturo ^b   Hebel, Eduardo ^c   Fierro, Jaqueline ^c   Klapp, Gabriela ^d   Venegas, Alejandro ^a   Harris, Paul R ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b Hospital Regional de Iquique   (Chile)

^c UNIVERSIDAD DE LA FRONTERA   (Chile)

^d Hospital Clínico Dr Lautaro Navarro Avaria   (Chile)

Author keywords

Cytokines; Gastroduodenal ulcer; Helicobacter pylori; Virulence factors

Indexed keywords

BACTERIAL DNA; CAGA PROTEIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; VACUOLATING TOXIN; VIRULENCE FACTOR;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; DUODENUM ULCER; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOST RESISTANCE; HUMAN; HUMAN TISSUE; MALE; MULTIPLE REGRESSION; NONHUMAN; PREDICTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ALLELES; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CHILD; CHILD, PRESCHOOL; CYTOKINES; DUODENAL ULCER; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; TH1 CELLS; TH2 CELLS; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 33947234988     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.12.012     Document Type: Article

References (30)

1. Sipponen P., Hyvarinen H., Seppala K., and Blazer M.J. Pathogenesis of the transformation from gastritis to malignacy. Aliment. Pharmacol. Ther 12 (1999) 61-71
2. Rollan A., Ferreccio C., Harris P., Serrano C., Jara A., and Venegas A. Early Helicobacter pylori infection is related to gastric cancer risk in Chile, a high-risk area: A population-based study. Can. J. Gastroenterol 4B (2005)
3. República de Chile. Ministerio de Salud. Departamento de Estadísticas. Bases de datos de Mortalidad 1990-2004. Available from http://deis.minsal.cl/. Accession: 25/08/2006.
4. Monack D.M., Mueller A., and Falkow S. Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat. Rev. Microbiol. 2 (2004) 747-765
5. Atherton J.C., Peek R.M., Tham K., Cover T., and Blaser M.J. Clinical and pathological importance of heterogeneity in VacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 112 (1997) 92-99
6. Gerhard M., Lehn N., Neumayer N., Boren T., Rad R., Schepp W., Miehlke S., Classen M., and Prinz C. Clinical relevance of the Helicobacter pylori gene for blood group antigen-binding adhesin. Proc. Natl. Acad. Sci. USA 96 (1999) 12778-12783
7. Crabtree J., Covacci A., Farmery S.M., Xiang Z., Tompkins D.S., Perry S., Lindley I., and Rappuoli R. Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J. Clin. Pathol 48 (1995) 41-45
8. Amieva M.R., Vogelmann R., Covacci A., Tompkins L.S., Nelson W., and Falkow S. Disrruption of epithelial apical-functional complex by Helicobacter pylori CagA. Science 300 (2003) 1430-1434
9. Wagner S., Beil W., Westermann J., et al. Regulation of gastric epithelial cell growth by Helicobacter pylori: evidence for a major role of apoptosis. Gastroenterology 113 (1997) 1836-1847
10. Sommer F., Faller G., Konturek P., et al. Antrum and corpus mucosa-infiltrating CD4+ lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect. Immun 6 (1998) 5543-5546
11. Raghavan S., Fredriksson M., Svennerholm A.M., Holmgren J., and Suri-Payer E. Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice. Clin. Exp. Immunol 132 (2003) 393-400
12. Smythies L., Waites K., Lindsey J., Harris P., Ghiara P., and Smith P. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-γ, gene-deficient mice. J. Immunol 165 (2000) 1022-1029
13. Díaz M.I., Valdivia A., Palacios J.L., Martínez P., Harris P., Novales J., Garrido E., Valderrama D., Shilling C., Kirberg A., Hebel E., Bravo R., Siegel F., Leon G., and Venegas A. The H. pylori vacA s1a and s1b alleles from clinical isolates from different regions of Chile show a distinct distribution along the country. W.J. Gastroenterol 11 (2005) 6366-6372
14. Goowin S. In: Clayton C.L., and Mobley L.T. (Eds). Methods in Molecular Medicine, Helicobacter pylori Protocols (1999), Humana Press, Totowa, NJ 7-13
15. Owen R., and Bickley J. In: Clayton C.L., and Mobley L.T. (Eds). Methods in Molecular Medicine, Helicobacter pylori Protocols (1999), Humana Press, Totowa, NJ 88-89
16. Tomb J.F., White O., et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388 (1997) 539-547
17. Muller I., Medina-Selby A., Palacios J.L., Martínez P., Opazo P., Bruce E., Mancilla M., Valenzuela P., Yudelevich A., and Venegas A. Cloning and comparison of ten gene sequences of a Chilean H. pylori strain with other H. pylori strains revealed higher variability for VacA and CagA virulence factors. Biol. Res. 35 (2002) 67-84
18. Valdivia A., Palacios J.L., Harris P., et al. El gen cagA de Helicobacter pylori de cepas de pacientes de Los Angeles (Chile) presenta distinto tamaño en la región codificante del dominio hidrofilico A17. Acta Microbiol. 8 (2002) 11-16
19. Yan J., Kumagai T., Ohnishi M., Ueno I., and Ota H. Immune response to a 26-kDa protein, alkyl hydroperoxide reductase in Helicobacter pylori-infected Mongolian gerbil. Helicobacter 6 (2001) 274-282
20. Atherton J.C., Cao P., Peek R., Tummuru M., Blaser M.J., and Cover T.L. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270 (1995) 17771-17777
21. Peek R., and Blaser M.J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2 (2002) 28-37
22. Crabtree J., Taylor J., Wyatt J., Heatley R., Shallcross T., Tompkins D., and Rathbone B. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration and gastric pathology. Lancet 338 (1991) 332-335
23. Cover T., Glupczynski Y., Lage A., Burette A., Tummuru M., Perez-Perez G., and Blazer M. Serologic detection of infection with cagA+ Helicobacter pylori strains. J. Clin. Microbiol. 33 (1995) 1496-1500
24. Van Doorn L., Figueiredo C., Sanna R., Plaisier A., Schneeberger P., De Boer W., and Quint W. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 115 (1998) 58-66
25. Pan Z., et al. Equally high prevalences of infection with cag positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia. J. Clin. Microbiol. 35 (1997) 1344-1347
26. Graham D., Genta R., Graham D., and Crabtree J. Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis. J. Clin. Pathol 49 (1996) 829-832
27. Yamaoka Y., Souchek J., Odenbreit S., et al. Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori. J. Clin. Microbiol. 40 (2002) 2244-2246
28. Maeda S., Ogura K., Yoshida H., et al. Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut 42 (1998) 338-343
29. Appelmelk B., Montiro M., Martin S., Moran A., and Vandenbroucke-Grauls C. Why Helicobacter pylori has a Lewis antigens. Trends Microbiol. 8 (2000) 565-570
30. Harris P., Godoy A., Arenillas S., et al. CagA Antibodies as a marker of virulence in Chilean patients with Helicobacter pylori Infection. J. Pediatr. Gastroenterol. Nutr 37 (2003) 596-602